Uploads by Yachao Liu

TS2-ExploratoryVsConfirmatoryResearchv2

The Levels of Evidence and their role in Evidence-Based 2011 rev.pdf

PIIS0923753419319076

CTS-10-84

1471-2288-11-57

Biomarkers in precision cancer immunotherapy

PD-L1 on tumor and immune cells 2017 rev.pdf

Teixidó C, 2018 review

PD-L1 prognostic NSCLC neo_2018_01_140

PD-L1 pitfalls membrane tumor and macrophage 2017

PD-L1 on tumor and immune cells 2017 rev.pdf

Naso 2020 PD-L1 22C3 LDT 263

Prestem_Suffixes_202003

Addendum_StemBook2018_202003

TIGIT as an emerging immune checkpoint_2019 rev

Alk TKI revew 2019

Entrectinib in ROS1 NSCLC study 2020

Tyrosine kinase inhibition of EGFR rev 2018_PIIS0923753419316734

TMB NSCLC 2020 rev

Galuppini 2019 review.pdf

Dung 2017 TMB PD-L1 pembro.pdf

Chan 2019 review

Talseth-Palmer 2015 Cancer Med

Stelloo Ann Oncol 2017

Moreira JAMA 2012

marabelle_kn158 tmb_esmo slides_final.pdf

Lee 2014 Genetic Test Mol Biomarker

jamaoncology_smyth_2017_oi_160106

jamaoncology_hampel_2018_oi_180007

CheckMate 142 2L Lancet 2017

Buchanan J Gastroenterol 2017

cancers-11-00877

10.1002-cncr.30370Figure303700001

1-s2.0-S1368837517300222-main

Lease Agreement_Template_2020 June

ddn drug discovery_Fishing for Parkinson

50 tips for wedding photo

FDA Medical Device Labeling